Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.26
0.00 (0.00%)
At close: Oct 02, 2025, 10:54 AM
Cocrystal Pharma Revenue Breakdown
| Period Ending | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|
| Collaboration Revenue Revenue | 489K | 554K |
| Collaboration Revenue Revenue Growth | -11.73% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 986K | 981K | 1.19M | 1.8M | 1.14M | 1.17M | 1.4M | 1.85M | 1.54M | 1.2M | 1.22M | 1.82M | 1.38M | 1.33M | 1.4M | 1.79M | 1.08M | 1.16M | 1M | 1.12M | 2.03M | 1.14M | 1.27M | 1.22M | 1.05M | 1.32M | 1.2M | 952K | 1.01M | 1.19M | 728K | 717K | -55K | 1.05M | 510K | -199K | 1.84M | 1.99M | 2.86M | 1.44M | 1.9M | 635K |
| Selling, General, and Administrative Revenue Growth | +0.51% | -17.77% | -33.72% | +57.89% | -2.81% | -16.15% | -24.34% | +20.22% | +27.74% | -0.91% | -33.32% | +32.51% | +3.15% | -4.58% | -21.87% | +65.40% | -6.89% | +15.52% | -10.35% | -44.72% | +78.05% | -10.03% | +3.52% | +16.37% | -20.56% | +10.71% | +25.53% | -6.02% | -14.87% | +63.46% | +1.53% | -1403.64% | -105.24% | +105.88% | -356.28% | -110.84% | -7.83% | -30.42% | +99.23% | -24.29% | +198.90% | n/a |
| Research and Development Revenue | 1.12M | 1.36M | 2.04M | 3.24M | 4.31M | 2.95M | 4.27M | 4.19M | 2.8M | 3.91M | 3.29M | 3.87M | 2.36M | 2.87M | 2.31M | 2.17M | 2.75M | 1.58M | 971K | 2.08M | 1.98M | 1.28M | 958K | 1.08M | 1.09M | 878K | 55.11M | 1.47M | 1.12M | 877K | 1.1M | 1.39M | 1.25M | 2.07M | 93.88M | 2.09M | 2.37M | 3.34M | 41.51M | 2.18M | 1.95M | 1.56M |
| Research and Development Revenue Growth | -17.50% | -33.24% | -37.17% | -24.74% | +46.03% | -30.86% | +1.74% | +49.73% | -28.31% | +18.86% | -15.11% | +64.00% | -17.79% | +24.60% | +6.47% | -21.19% | +74.19% | +62.41% | -53.25% | +5.11% | +54.01% | +33.92% | -11.05% | -1.28% | +24.26% | -98.41% | +3656.51% | +31.10% | +27.59% | -20.56% | -20.75% | +11.00% | -39.40% | -97.79% | +4385.24% | -11.61% | -29.14% | -91.95% | +1806.75% | +11.87% | +24.74% | n/a |